Gapping up
In reaction to strong earnings/guidance: VTNR +8.3%, SONC +6.8%, SOL +4.9% (also upgraded to Buy from Neutral at ROTH Capital), EXA +3.5% (thinly traded), WAG +0.3%, (light volume).
M&A related: RBS +1.1% (Mitsubishi Financial also considering bid for Citizens Group, according to reports, DIS +0.4% (to acquire Maker Studies for total consideration of $500 mln and a performance-linked earn-out of up to $450 mln).
Select financial related names showing strength: NBG +2.7%, DB +1.2%, ING +0.8% (to pay EUR 1.225 billion to Dutch State), BAC +0.3% (Barron's profiles positive view).
Metals/mining stocks trading higher: RIO +2.3%, ABX +1.5%, BHP +1.4%, AU +1.4%, IAG +1.4%, GDX +1.2%, GOLD +1.1%, SLV +0.7%.
Select solar related names showing strength: RGSE +3.3%, TSL +2.7%, JKS +2.2%.
Other news: OFIX +8.9% (announces filing of restated financial statements ), CCIH +8.8% (was added to NASDAQ Golden Dragon China Index yesterday), WUBA +7.8% (announced offering yesterday), HALO +5.9% (announces positive results from Phase 1/2 Clinical Trial In Cellulite With HTI-501), RLD +4.5% (RealD and Wanda Cinema sign agreement to add 780 RealD 3D Cinema Systems across China), PLUG +4.4% (lifting premarket on positive blog comments), LUX +3% (to develop and distribute a new breed of eyewear for Glass), CPRX +1.8% (announced that the independent Data Monitoring Committee overseeing the Co's ongoing pivotal Phase 3 clinical trial evaluating Firdapse for the treatment of Lambert-Eaton Myasthenic Syndrome recommended that the trial be continued as planned), UN +1.4% (still checking), AWAY +1.2% (announces proposed $350 mln offering of convertible senior notes due 2019), TWTR +1.1% (still checking), BUD +1% (still checking), WEN +0.9% (announces completion of its System Optimization initiative with sale of 104 restaurants in four U.S. markets), FEYE +0.8% (modestly rebounding; also initiated in-line at Imperial Capital;), NFX +0.7% (after appearance on Mad Money), RDS.A +0.6% ( plans to focus on large projects amid spending cuts, according to reports).
Analyst comments: ECYT +10.3% (added to Best Ideas List at Wedbush), NPSP +5.3% (initiated with a Buy at Goldman), VRNS +4.1% (several analyst initiations), RAX +3.3% (light volume, upgraded to Overweight from Equal Weight at Morgan Stanley), ARIA +2% (Ariad Pharm resumed with a Buy from Neutral at HC Wainwright; tgt $14), PANW +1.7% (upgraded to Outperform from Mkt Perform at FBR Capital), SINA +1.6% ( attributed to positive JPMorgan comments related Weibo), SAPE +1% ( initiated with a Buy at Sun Trust Rbsn Humphrey), ORAN +1% (upgraded to Hold from Reduce at Kepler), CVG +1% (initiated with a Buy at Sun Trust Rbsn Humphrey), E +0.8% (upgraded to Outperform from Market Perform at Raymond James)
M&A related: RBS +1.1% (Mitsubishi Financial also considering bid for Citizens Group, according to reports, DIS +0.4% (to acquire Maker Studies for total consideration of $500 mln and a performance-linked earn-out of up to $450 mln).
Select financial related names showing strength: NBG +2.7%, DB +1.2%, ING +0.8% (to pay EUR 1.225 billion to Dutch State), BAC +0.3% (Barron's profiles positive view).
Metals/mining stocks trading higher: RIO +2.3%, ABX +1.5%, BHP +1.4%, AU +1.4%, IAG +1.4%, GDX +1.2%, GOLD +1.1%, SLV +0.7%.
Select solar related names showing strength: RGSE +3.3%, TSL +2.7%, JKS +2.2%.
Other news: OFIX +8.9% (announces filing of restated financial statements ), CCIH +8.8% (was added to NASDAQ Golden Dragon China Index yesterday), WUBA +7.8% (announced offering yesterday), HALO +5.9% (announces positive results from Phase 1/2 Clinical Trial In Cellulite With HTI-501), RLD +4.5% (RealD and Wanda Cinema sign agreement to add 780 RealD 3D Cinema Systems across China), PLUG +4.4% (lifting premarket on positive blog comments), LUX +3% (to develop and distribute a new breed of eyewear for Glass), CPRX +1.8% (announced that the independent Data Monitoring Committee overseeing the Co's ongoing pivotal Phase 3 clinical trial evaluating Firdapse for the treatment of Lambert-Eaton Myasthenic Syndrome recommended that the trial be continued as planned), UN +1.4% (still checking), AWAY +1.2% (announces proposed $350 mln offering of convertible senior notes due 2019), TWTR +1.1% (still checking), BUD +1% (still checking), WEN +0.9% (announces completion of its System Optimization initiative with sale of 104 restaurants in four U.S. markets), FEYE +0.8% (modestly rebounding; also initiated in-line at Imperial Capital;), NFX +0.7% (after appearance on Mad Money), RDS.A +0.6% ( plans to focus on large projects amid spending cuts, according to reports).
Analyst comments: ECYT +10.3% (added to Best Ideas List at Wedbush), NPSP +5.3% (initiated with a Buy at Goldman), VRNS +4.1% (several analyst initiations), RAX +3.3% (light volume, upgraded to Overweight from Equal Weight at Morgan Stanley), ARIA +2% (Ariad Pharm resumed with a Buy from Neutral at HC Wainwright; tgt $14), PANW +1.7% (upgraded to Outperform from Mkt Perform at FBR Capital), SINA +1.6% ( attributed to positive JPMorgan comments related Weibo), SAPE +1% ( initiated with a Buy at Sun Trust Rbsn Humphrey), ORAN +1% (upgraded to Hold from Reduce at Kepler), CVG +1% (initiated with a Buy at Sun Trust Rbsn Humphrey), E +0.8% (upgraded to Outperform from Market Perform at Raymond James)